Finally, a recent has described MDK levels in the cerebrospinal fluid of Parkinson’s disease (PD) patients as a supportive diagnostic biomarker (130), highlighting its potential for other neurodegenerative disease such as MS or AD. Here, MDK is linked to neurodegenerative disease.